Ana Rabaça
Portugal
Research Article
Assessing Male Reproductive Toxicity during Drug Development
Author(s): Mário Sousa, Carolina Ferreira, Ana Rabaça and Rosália SáMário Sousa, Carolina Ferreira, Ana Rabaça and Rosália Sá
Pharmaceutical development is a crucial research field that attends to the population healthcare needs, comprising several preclinical and clinical steps before the approval of a new compound. Interestingly, the lack of efficacy and toxicity are known major failure causes during pharmaceutical drug development. Toxicity screening is therefore a mandatory procedure during pharmaceutical development. Renal and hepatic toxicity are the most common toxicity matters encountered during the development of new compounds. Nonetheless, the male reproductive system may also be a target for drug toxicity. However, developmental and reproductive toxicology testing is rarely performed both in pre-clinical and clinical trial phases. As a result, there are several risks for human fertility brought on by putative toxic chemical compounds. As there is a low incidence of reproductive and testicular toxi.. View More»
